{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:38:41Z","timestamp":1792237121325,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1124\/dmd.111.044446","type":"journal-article","created":{"date-parts":[[2012,2,11]],"date-time":"2012-02-11T05:30:06Z","timestamp":1328938206000},"page":"970-981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Metabolism, Pharmacokinetics, Tissue Distribution, and Stability Studies of the Prodrug Analog of an Anti-Hepatitis B Virus Dinucleoside Phosphorothioate"],"prefix":"10.1016","volume":"40","author":[{"given":"John E.","family":"Coughlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra K.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seetharamaiyer","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen G.","family":"O\u2019Loughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Marquis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol E.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon C.","family":"Mirsalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhakrishnan P.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.111.044446_bib1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0006-2952(95)00160-2","article-title":"Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administration","volume":"50","author":"Agrawal","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.111.044446_bib2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0008-8749(85)90104-2","article-title":"8-Hydroxyguanosine and 8-methoxyguanosine possess immunostimulating activity for B lymphocytes","volume":"94","author":"Ahmad","year":"1985","journal-title":"Cell Immunol"},{"key":"10.1124\/dmd.111.044446_bib3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1124\/dmd.111.044446_bib4","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0040-4020(01)88752-4","article-title":"Advances in the synthesis of oligonucleotides by the phosphoramidite approach","volume":"48","author":"Beaucage","year":"1992","journal-title":"Tetrahedron"},{"key":"10.1124\/dmd.111.044446_bib5","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.bmcl.2010.01.010","article-title":"Orally bioavailable anti-HBV dinucleotide acyloxyalkyl prodrugs","volume":"20","author":"Coughlin","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/dmd.111.044446_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0022-3565(24)35270-X","article-title":"Metabolism of antisense oligonucleotides in rat liver homogenates","volume":"292","author":"Crooke","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.111.044446_bib7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/tx8004357","article-title":"Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites","volume":"22","author":"Dalvie","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.111.044446_bib8","first-page":"347","article-title":"Antisense oligonucleotides: basic concepts and mechanisms","volume":"1","author":"Dias","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/dmd.111.044446_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1387-2656(08)70052-8","article-title":"Aptamers as potential nucleic acid pharmaceuticals","volume":"1","author":"Ellington","year":"1995","journal-title":"Biotechnol Annu Rev"},{"key":"10.1124\/dmd.111.044446_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1517\/17425250902877680","article-title":"Antisense oligonucleotide pharmacokinetics and metabolism","volume":"5","author":"Geary","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.111.044446_bib11","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/jps.2600600909","article-title":"Influence of first-pass effect on availability of drugs on oral administration","volume":"60","author":"Gibaldi","year":"1971","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.111.044446_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/418244a","article-title":"RNA interference","volume":"418","author":"Hannon","year":"2002","journal-title":"Nature"},{"key":"10.1124\/dmd.111.044446_bib13","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1093\/nar\/gkh948","article-title":"Diversity-oriented solid-phase synthesis and biological evaluation of oligonucleotide hairpins as HIV-1 RT RNase H inhibitors","volume":"32","author":"Hannoush","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/dmd.111.044446_bib14","first-page":"395","article-title":"Antisense oligonucleotide inhibitors for the treatment of cancer: 2. Toxicological properties of phosphorothioate oligodeoxynucleotides","volume":"12","author":"Henry","year":"1997","journal-title":"Anticancer Drug Des"},{"key":"10.1124\/dmd.111.044446_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/019262339902700117","article-title":"Correlation of toxicity and pharmacokinetic properties of a phosphorothioate oligonucleotide designed to inhibit ICAM-1","volume":"27","author":"Henry","year":"1999","journal-title":"Toxicol Pathol"},{"key":"10.1124\/dmd.111.044446_bib16","series-title":"Guide for the Care and Use of Laboratory Animals","year":"1996"},{"key":"10.1124\/dmd.111.044446_bib17","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/ja00159a059","article-title":"3H-1,2-benzodithiol-3-one 1, 1-dioxide as an improved sulfurizing reagent in the solid-phase synthesis of oligodeoxyribonucleoside phosphoramidites","volume":"112","author":"Iyer","year":"1990","journal-title":"J Am Chem Soc"},{"key":"10.1124\/dmd.111.044446_bib18","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/jo00302a039","article-title":"The automated synthesis of sulfur-containing oligodeoxyribonucleotides using 3H-1,2-benzodithiol-3-one-1, 1-dioxide as a sulfur-transfer reagent","volume":"55","author":"Iyer","year":"1990","journal-title":"J Org Chem"},{"key":"10.1124\/dmd.111.044446_bib19","doi-asserted-by":"crossref","first-page":"9521","DOI":"10.1016\/0040-4039(94)88501-X","article-title":"Synthesis of [35S]-3H-1, 2-benzodithiol-3-one-1,1-dioxide: application in the preparation of site-specifically 35S-labeled oligonucleotides","volume":"35","author":"Iyer","year":"1994","journal-title":"Tetrahedron Lett"},{"key":"10.1124\/dmd.111.044446_bib20","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1128\/AAC.48.6.2199-2205.2004","article-title":"Phosphorothioate di- and trinucleotides as a novel class of anti-hepatitis B virus agents","volume":"48","author":"Iyer","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.111.044446_bib21","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1128\/AAC.48.6.2318-2320.2004","article-title":"Anti-hepatitis B virus activity of ORI-9020, a novel phosphorothioate dinucleotide, in a transgenic mouse model","volume":"48","author":"Iyer","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.111.044446_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/00304940509354949","article-title":"Rapid functionalization and loading of solid supports","volume":"37","author":"Iyer","year":"2005","journal-title":"Org Prep Proc Int"},{"key":"10.1124\/dmd.111.044446_bib23","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.coph.2005.04.019","article-title":"Nucleotide analogs as novel anti-hepatitis B virus agents","volume":"5","author":"Iyer","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/dmd.111.044446_bib24","series-title":"Abstracts of the 19th International Conference on Antiviral Research; 2006 Apr 29\u2013May 3; Palm Springs, CA.","article-title":"Metabolism and pharmacokinetic studies of SB 9000\u2013a novel anti-HBV agent","author":"Iyer","year":"2006"},{"key":"10.1124\/dmd.111.044446_bib25","series-title":"Abstracts of the 23rd International Conference on Antiviral Research; 2010 Apr 25\u201327; San Francisco, CA.","article-title":"Activation of retinoic acid inducible gene (RIG-I) by nucleotide analogs\u2013a potential novel mechanism for antiviral discovery","author":"Iyer","year":"2010"},{"key":"10.1124\/dmd.111.044446_bib26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nri888","article-title":"Viruses and interferon: a fight for supremacy","volume":"2","author":"Katze","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/dmd.111.044446_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1742-7843.2009.00464.x","article-title":"The consideration of synthetic short interfering RNA for therapeutic use","volume":"106","author":"Li","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/dmd.111.044446_bib28","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/nbt1161","article-title":"Activation of the mammalian immune system by siRNAs","volume":"23","author":"Marques","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1124\/dmd.111.044446_bib29","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1126\/science.1168352","article-title":"Cytosolic viral sensor RIG-I is a 5\u2032-triphosphate-dependent translocase on double-stranded RNA","volume":"323","author":"Myong","year":"2009","journal-title":"Science"},{"key":"10.1124\/dmd.111.044446_bib30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1021\/cr00081a006","article-title":"Structural basis of protein-nucleic acid interactions","volume":"87","author":"Ollis","year":"1987","journal-title":"Chem Rev"},{"key":"10.1124\/dmd.111.044446_bib31","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.bmcl.2005.12.058","article-title":"Anti-HBV nucleotide prodrug analogs: synthesis, bioreversibility, and cytotoxicity studies","volume":"16","author":"Padmanabhan","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/dmd.111.044446_bib32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.tetlet.2004.09.189","article-title":"Microwave-assisted functionalization of solid supports. Application in the rapid loading of nucleosides on controlled-pore-glass (CPG)","volume":"46","author":"Padmanabhan","year":"2005","journal-title":"Tetrahedron Lett"},{"key":"10.1124\/dmd.111.044446_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/108729001750072092","article-title":"Tissue distribution and physiologically based pharmacokinetics of antisense phosphorothioate oligonucleotides ISIS 1082 in rat","volume":"11","author":"Peng","year":"2001","journal-title":"Antisense Nucleic Acid drug Dev"},{"issue":"Suppl 1","key":"10.1124\/dmd.111.044446_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2004-828675","article-title":"Overview of treatment of hepatitis B: key approaches and clinical challenges","volume":"24","author":"Perrillo","year":"2004","journal-title":"Semin Liver Dis"},{"key":"10.1124\/dmd.111.044446_bib35","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1074\/jbc.M007746200","article-title":"Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib)","volume":"276","author":"Ritzel","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.111.044446_bib36","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/ni.1782","article-title":"Activation of innate immune antiviral responses by Nod2","volume":"10","author":"Sabbah","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1124\/dmd.111.044446_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/protein\/gzj002","article-title":"An empirical approach for detecting nucleotide-binding sites on proteins","volume":"19","author":"Saito","year":"2006","journal-title":"Protein Eng Des Sel"},{"key":"10.1124\/dmd.111.044446_bib38","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1073\/pnas.0606699104","article-title":"Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2","volume":"104","author":"Saito","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.111.044446_bib39","series-title":"Principles of Nucleic Acid Structure","author":"Sanger","year":"1983"},{"key":"10.1124\/dmd.111.044446_bib40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/1520-6017(200104)90:4<448::AID-JPS1003>3.0.CO;2-H","article-title":"New bis(SATE) prodrug of AZT 5\u2032-monophosphate: in vitro anti-HIV activity, stability, and potential oral absorption","volume":"90","author":"Shafiee","year":"2001","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.111.044446_bib41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1359-6446(96)80008-0","article-title":"Developing antisense oligonucleotides from the laboratory to clinical trials","volume":"1","author":"Szymkowski","year":"1996","journal-title":"Drug Disc Today"},{"key":"10.1124\/dmd.111.044446_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jps.21084","article-title":"Oral delivery of antisense oligonucleotides in man","volume":"97","author":"Tillman","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.111.044446_bib43","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.1184004","article-title":"How the noninflammasome NLRs function in the innate immune system","volume":"327","author":"Ting","year":"2010","journal-title":"Science"},{"key":"10.1124\/dmd.111.044446_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/1439-7633(20010401)2:4<239::AID-CBIC239>3.0.CO;2-R","article-title":"RNA interference and small interfering RNAs","volume":"2","author":"Tuschl","year":"2001","journal-title":"Chembiochem"},{"key":"10.1124\/dmd.111.044446_bib45","series-title":"The National Formulary 18","first-page":"1788","year":"1993"},{"key":"10.1124\/dmd.111.044446_bib46","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1124\/dmd.106.009555","article-title":"Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules","volume":"34","author":"van de Water","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.044446_bib47","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nbt0796-840","article-title":"Potent and selective inhibition of gene expression by an antisense heptanucleotide","volume":"14","author":"Wagner","year":"1996","journal-title":"Nat Biotechnol"},{"key":"10.1124\/dmd.111.044446_bib48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/ar50003a002","article-title":"Pseudo-rotation in the hydrolysis of phosphate esters","volume":"1","author":"Westheimer","year":"1968","journal-title":"Acc Chem Res"},{"key":"10.1124\/dmd.111.044446_bib49","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/ddr.10376","article-title":"Drug ADME-associated protein database as a resource for facilitating pharmacogenomics research","volume":"62","author":"Zheng","year":"2004","journal-title":"Drug Dev Res"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624226787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624226787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.111.044446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T20:08:06Z","timestamp":1739909286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624226787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0090955624226787"],"URL":"https:\/\/doi.org\/10.1124\/dmd.111.044446","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolism, Pharmacokinetics, Tissue Distribution, and Stability Studies of the Prodrug Analog of an Anti-Hepatitis B Virus Dinucleoside Phosphorothioate","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.111.044446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}